Archive · 1 Aug 2025
Trump Softens Drug Price Demands in New Push
President Trump is asking 17 big drug companies to lower their prices, but his demands have become less strict.
He wants these companies to match the prices other rich countries pay for certain medicines, but only for some of the drugs and only for low-income people.
His previous plan was more wide-ranging.
Drug company stocks fell after the announcement, while the pharmaceutical lobby group is against the effort, saying it could hurt American innovation and leadership in the field.
Trump sent letters to 17 pharmaceutical companies demanding lower drug prices.
He wants companies to lower prices for drugs on the market to 'most-favored-nation' rates for Medicaid.
For other payers, the rates should apply only to newly launched medicines.
The S&P 500 Pharmaceuticals index dropped 2.7% in response.
PhRMA criticized the effort, saying it would undermine American leadership.
- Who
- President Trump and 17 pharmaceutical companies.
- What
- Trump demanded 17 pharmaceutical companies lower prices.
- When
- Late September is the compliance deadline.
- Where
- United States
- Why
- To lower drug prices for American consumers.
Trump's Stance
PhRMA
Drug Pricing
Trump's Stance
Seeks lower drug prices.
PhRMA
Not specified.
Government Action
Trump's Stance
Will deploy every tool to protect American families.
PhRMA
Not specified.
- Companies Targeted
- AbbVie, Bristol Myers Squibb, Novartis, Gilead Sciences, Pfizer, Regeneron and others
- Stock Impact
- S&P 500 Pharmaceuticals index fell 2.7%
- Policy Demand
- Lower prices for some drugs for Medicaid and newly launched medicines for other payers
- Compliance Timeframe
- Late September
- Criticism
- PhRMA opposes the effort, citing potential harm to innovation.
Sources
Trump Warns Pharma Companies To Cut Prices Or Be Punished
'American families deserve immediate relief': US drug prices too high? Trump threatens crackdown on 17 major pharmaceutical giants
President Trump demands pharma giants slash US drug prices; stocks drop
Trump demands drug companies slash US prices in blow to industry
Sun Pharma shares fall after big drugmakers get Trump letters; Sandeep Bhatia explains why
Trump asks 17 non-Indian drug majors to cut prices in US; Nifty pharma dips
Trump Tells 17 Global Drug Firms To Cut Prices In US, Nifty Pharma Falls Amid Market Concerns
